REGENXBIO Inc. (RGNX): Price and Financial Metrics


REGENXBIO Inc. (RGNX)

Today's Latest Price: $48.38 USD

0.72 (-1.47%)

Updated Jan 17 2:36pm

Add RGNX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 322 in Biotech

See all "A" rated Strong Buy stocks

RGNX Stock Summary

  • With a price/sales ratio of 26.87, REGENXBIO Inc has a higher such ratio than 95.4% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.07 for REGENXBIO Inc; that's greater than it is for merely 7.21% of US stocks.
  • Revenue growth over the past 12 months for REGENXBIO Inc comes in at -64.26%, a number that bests just 2.34% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to RGNX, based on their financial statements, market capitalization, and price volatility, are CLDX, APTX, AGTC, IMGN, and SURF.
  • RGNX's SEC filings can be seen here. And to visit REGENXBIO Inc's official web site, go to www.regenxbio.com.
RGNX Daily Price Range
RGNX 52-Week Price Range

RGNX Stock Price Chart More Charts


RGNX Price/Volume Stats

Current price $48.38 52-week high $63.21
Prev. close $49.10 52-week low $30.38
Day low $48.36 Volume 287,132
Day high $50.09 Avg. volume 488,907
50-day MA $41.38 Dividend yield N/A
200-day MA $43.08 Market Cap 1.78B

REGENXBIO Inc. (RGNX) Company Bio


REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company was founded in 2009 and is based in Rockville, Maryland.





RGNX Latest News Stream


Event/Time News Detail
Loading, please wait...

RGNX Latest Social Stream


Loading social stream, please wait...

View Full RGNX Social Stream

RGNX Price Returns

1-mo 17.48%
3-mo 28.16%
6-mo -1.53%
1-year 6.82%
3-year 151.32%
5-year N/A
YTD 18.09%
2019 -2.34%
2018 26.17%
2017 79.25%
2016 11.75%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5543 seconds.